Contact Us
Click here to contact Felicity Thomas,editor.
October 29, 2014
MS and uveitis Study examines link between MS and uveitis The findings of a new study will enable clinicians to make more accurate diagnoses of multiple sclerosis (MS) and uveitis while giving people a better understanding of their prognoses, according to its authors.More...
Combination eye drop Combination glaucoma drop moves toward approval A preservative-free IOP-lowering eye drop that is a combination of tafluprost and timolol (Taptiqon, Santen) is seeking national licences in European countries after a positive decentralized procedure and a final assessment report from reference member state Germany, the Federal Institute for Drugs and Medical Devices of Germany, and agreement by concerned member states that the fixed-dose product is approvable. More...
BCVA in DME Aflibercept boosts BCVA in DME Patients with diabetic macular oedema (DME) who received aflibercept injection (EYLEA, Bayer HealthCare) demonstrated a significantly greater improvement in mean change in best-corrected visual acuity (BCVA) from baseline at 52 weeks compared to those who received either bevacizumab or ranibizumab. More...
Products in Practice Issue 3
Real world experience of leading ophthalmic products.
Read more:
